USRC Kidney Research
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, USRC Kidney Research sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
USRC Kidney Research: 4 sponsored US clinical trials, none currently recruiting.
USRC Kidney Research sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 4 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Renal Anemia, with 2 trials.
Upper-quartile sponsor footprint
USRC Kidney Research sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Vafseo Outcomes In-Center Experience
NCT06520826
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
NCT05951192
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
NCT05085275
Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants
NCT04922645
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
How the USRC Kidney Research archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase mix: 4 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Renal Anemia (2 trials), 8 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
USRC Kidney Research: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
USRC Kidney Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this USRC Kidney Research page
4 registered trials is a research-attention snapshot, not an endorsement of USRC Kidney Research or any single study.
- None of USRC Kidney Research's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Renal Anemia is the condition USRC Kidney Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Renal Anemia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. USRC Kidney Research pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.